|
|
|
CfPA-The Center for Professional Advancement, Online Live
May 30, 2017 at 11:00 a.m.–12:30 p.m. (ET)
Who Should Attend? You are charged with exploring or implementing a QbD effort within your organization. The documents that explain the Quality-by-Design concept devote twenty pages to the aims, goals and expectations of QbD in the Pharma manufacturing industry. Your team is formed, at least on paper. Now what do you do? The QbD core elements; Knowledge Base, Risk Management and Experimentation are in the documents but you need to understand them and make them work within your company and product needs. This course provides a guide to extracting the resources that you will need from your internal operations (knowledge base;) establish and apply metrics that take risk management out of the conceptual framework; and will suggest tools that simplify your experiments. It is intended for:
• QbD project managers • QbD team members • New product unit managers • Analytical method developers • Technology transfer specialists • Personnel concerned with process analysis and control • Unit operations staff Course Description
|
|
|
|
|
|
Organized by:
|
|
CfPA-The Center for Professional Advancement |
|
Invited Speakers:
|
|
John E. Carroll, C.Ph.C., CEO, Carroll Brands, Director, Cadrai Group |
John E. Carroll, C.Ph.C., is CEO of Carroll Brands and Director, Cadrai Group. The Cadrai Group develops and presents focused training programs for issues germane to the current needs of the pharmaceutical industry including small-molecule, biologic and nutraceutical preparations. Cadrai has an equally strong focus in both training and business development for the analytical instrument industry. Among Cadrai successes are: ion-mobility spectrometry for cleaning verification, NIR dedicated to tablet & capsule analysis, laser induced breakdown spectroscopy, chemical imaging and automated dissolution.
As Pharmaceutical Business Unit Manager for Perstorp Analytical Instruments (now Foss), Mr. Carroll built a global, sustainable business that saw over 8,000 NIR test instruments placed within the pharmaceutical manufacturing industry.
Mr. Carroll has a B.A.S in Engineering Technology/Chemistry, an M.B.A. (c) in International Marketing, sixty publications and numerous technical presentations. He is the author of “The NIR Desk Reference” (Carroll, He and Landa) and “The Handbook of FTIR” (Carroll). He is also the editor of “IR-MS: High sensitivity and selectivity for organic analysis” (Mattson and Carroll). Professional memberships include AAPS, ACS, CNIRS and ISPE.
|
|
|
|
|
|
Deadline for Abstracts:
|
|
n/a
|
|
|
|
|
|
Registration:
|
|
Please click here for registration information.
|
|
E-mail:
|
|
jmorbit@cfpa.com
|
|
|
|
|
|
|
|
Can't Make this LIVE Webinar?
Simply select the On Demand option when registering and we will send you the link to view the recorded version.
This course will be available On Demand: May 31, 2017